Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
124.04
-2.12 (-1.68%)
Streaming Delayed Price
Updated: 9:54 AM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
674,787
Open
123.69
Bid (Size)
124.02 (3)
Ask (Size)
124.06 (2)
Prev. Close
126.16
Today's Range
123.21 - 124.33
52wk Range
75.56 - 138.28
Shares Outstanding
N/A
Dividend Yield
1.43%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) a Strong Candidate for Quality Investing?
Today 7:00 EDT
Why NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) qualifies as a quality stock.
Via
Chartmill
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
April 24, 2024
Senate Committee probes Novo Nordisk's pricing tactics for diabetes and obesity meds. Sanders demands transparency on pricing, signaling broader industry scrutiny. Medicare coverage expansion could...
Via
Benzinga
Performance
YTD
+21.48%
+21.48%
1 Month
-3.88%
-3.88%
3 Month
+17.90%
+17.90%
6 Month
+27.31%
+27.31%
1 Year
+47.16%
+47.16%
More News
Read More
3 Biotech Stocks With Skyrocketing Potential: April 2024
April 24, 2024
Via
InvestorPlace
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
April 24, 2024
Via
The Motley Fool
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
Via
InvestorPlace
Why Novo Nordisk Topped the Market Today
April 22, 2024
Via
The Motley Fool
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Via
The Motley Fool
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
Via
The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
April 23, 2024
Via
InvestorPlace
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
April 22, 2024
Via
Benzinga
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
Via
MarketBeat
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
April 20, 2024
Via
The Motley Fool
MarketBeat Week in Review – 4/15 - 4/19
April 20, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
3 Relatively Safe Growth Stocks You Can Buy and Hold
April 20, 2024
Via
The Motley Fool
3 Biotech Stocks Set to Double by 2028
April 20, 2024
Via
InvestorPlace
Got $500? 3 Healthcare Stocks to Buy and Hold Forever
April 19, 2024
Via
The Motley Fool
German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline
April 18, 2024
Via
Benzinga
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
April 18, 2024
Via
Benzinga
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
April 18, 2024
Via
Investor's Business Daily
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
April 17, 2024
Via
The Motley Fool
Powell And The Great Indecision
April 16, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Interest Rates
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
April 16, 2024
Via
InvestorPlace
Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges
April 16, 2024
Via
InvestorPlace
Topics
ETFs
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Via
Talk Markets
3 Pharma Stocks That Are Money-Printing Machines in 2024
April 15, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.